Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A cell-based high-throughput screen to identify synergistic TRAIL sensitizers

16 Dec 2008

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autophagy in Disease and Therapy
Share to Cancer-related Molecular Pathways
Share to Cell death mechanisms and regulation

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 19089423
DOI: 10.1007/s00262-008-0637-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A cell-based high-throughput screen to identify synergistic TRAIL sensitizersPMID 19089423Read ↗

Targeting pan-essential pathways in cancer with cytotoxic chemotherapy: challenges and opportunitiesSemantic proximity Read ↗

Challenges and the Advancement in High-Throughput Screening Strategies for Cancer TherapeuticsSemantic proximity Read ↗

State of Art and Recent Developments of Anti-Cancer Strategies Based on TRAILSemantic proximity Read ↗

High-throughput screening reveals higher synergistic effect of MEK inhibitor combinations in colon cancer spheroidsSemantic proximity Read ↗

Mechanisms of cancer cell death induction by paclitaxel: an updated reviewSemantic proximity Read ↗

Methods for High-Throughput Drug Combination Screening and Synergy ScoringSemantic proximity Read ↗

Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination TreatmentSemantic proximity Read ↗

On the Design of Combination Cancer TherapySemantic proximity Read ↗

Rationale and clinical use of multitargeting anticancer agentsSemantic proximity Read ↗

Targeting of cancer cell death mechanisms by resveratrol: a reviewSemantic proximity Read ↗

Designed Multiple Ligands for Cancer TherapySemantic proximity Read ↗

An update on PARP inhibitors—moving to the adjuvant settingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.